This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dressman, M. A. Articles by Polymeropoulos, M. H. Search for Related Content PubMed PubMed Citation Articles by Dressman, M. A. Articles by Polymeropoulos, M. H.

Gene Expression Profiling Detects Gene Amplification and Differentiates Tumor Types in Breast Cancer

Clinical Pharmacogenetics Department, Novartis Pharmaceuticals Corporation, Gaithersburg, Maryland 20878 [M. A. D., A. B., R. M., L. B. A., I. K., M. H. P.], and Department of Biomedicine and Surgery, Division of Oncology, Faculty of Health Sciences, Linköping University, S-581 85 Linköping, Sweden [T. M. Z.]

Global gene expression analysis using microarrays has been used to characterize the molecular profile of tumors. Gene expression variability at the mRNA level can be caused by a number of different events, including novel signaling, downstream activation of transcription enhancers or silencers, somatic mutation, and genetic amplification or deletion. Genomic amplifications are commonly observed in cancer and often include known oncogenes. The tyrosine kinase-type cell surface receptor, ERBB2, is an oncogene located on chromosome 17q21.1 that is amplified in 10–40% of breast tumors. We report for the first time that phenylethanolamine N-methyltransferase (PNMT), proteasome subunit, ß type 3 (PSMB3), ribosomal protein L19 (RPL19), and nuclear receptor subfamily 1, group D, member 1 (NR1D1) are coexpressed with ERBB2 in 34 breast cancer biopsies and also mapped within the same chromosomal location as the ERBB2 gene. Consistent with previous reports, we also observed that the steroidogenic acute regulatory protein-related gene, MLN64, and growth factor receptor bound protein 7 were coexpressed with ERBB2. Coexpression and colocalization of PNMT and MLN64 with ERBB2 suggested that the amplification of ERBB2 includes the chromosomal region harboring these genes. This hypothesis was validated in a subset of 12 biopsies. Gene amplification of ERBB2, PNMT, and MLN64 significantly correlated with increased mRNA gene expression (P < 0.05). These results suggest that gene expression profiling of breast biopsies may become a valuable method for adequately characterizing and choosing treatment modality for patients with breast cancer.

This article has been cited by other articles:

				E. H. AHN, C.-C. CHANG, and D. A. TALMAGE Loss of Anti-proliferative Effect of All-trans Retinoic Acid in Advanced Stage of Breast Carcinogenesis Anticancer Res, August 1, 2009; 29(8): 2899 - 2904. [Abstract] [Full Text] [PDF]

				G. Deblois, J. A. Hall, M.-C. Perry, J. Laganiere, M. Ghahremani, M. Park, M. Hallett, and V. Giguere Genome-Wide Identification of Direct Target Genes Implicates Estrogen-Related Receptor {alpha} as a Determinant of Breast Cancer Heterogeneity Cancer Res., August 1, 2009; 69(15): 6149 - 6157. [Abstract] [Full Text] [PDF]

				A. Belkhiri, A. A. Dar, D. F. Peng, M. H. Razvi, C. Rinehart, C. L. Arteaga, and W. El-Rifai Expression of t-DARPP Mediates Trastuzumab Resistance in Breast Cancer Cells Clin. Cancer Res., July 15, 2008; 14(14): 4564 - 4571. [Abstract] [Full Text] [PDF]

				L. M. Davis, C. Harris, L. Tang, P. Doherty, P. Hraber, Y. Sakai, T. Bocklage, K. Doeden, B. Hall, J. Alsobrook, et al. Amplification Patterns of Three Genomic Regions Predict Distant Recurrence in Breast Carcinoma J. Mol. Diagn., July 1, 2007; 9(3): 327 - 336. [Abstract] [Full Text] [PDF]

				S. K Gruvberger-Saal, H. E Cunliffe, K. M Carr, and I. A Hedenfalk Microarrays in breast cancer research and clinical practice - the future lies ahead Endocr. Relat. Cancer, December 1, 2006; 13(4): 1017 - 1031. [Abstract] [Full Text] [PDF]

				P Kauraniemi and A Kallioniemi Activation of multiple cancer-associated genes at the ERBB2 amplicon in breast cancer. Endocr. Relat. Cancer, March 1, 2006; 13(1): 39 - 49. [Abstract] [Full Text] [PDF]

				H. Fiegl, S. Millinger, G. Goebel, E. Muller-Holzner, C. Marth, P. W. Laird, and M. Widschwendter Breast Cancer DNA Methylation Profiles in Cancer Cells and Tumor Stroma: Association with HER-2/neu Status in Primary Breast Cancer Cancer Res., January 1, 2006; 66(1): 29 - 33. [Abstract] [Full Text] [PDF]

				S. Gery, A. F. Gombart, W. S. Yi, C. Koeffler, W.-K. Hofmann, and H. P. Koeffler Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemia Blood, October 15, 2005; 106(8): 2827 - 2836. [Abstract] [Full Text] [PDF]

				F. Alpy and C. Tomasetto Give lipids a START: the StAR-related lipid transfer (START) domain in mammals J. Cell Sci., July 1, 2005; 118(13): 2791 - 2801. [Abstract] [Full Text] [PDF]

				F. Alpy, V. K. Latchumanan, V. Kedinger, A. Janoshazi, C. Thiele, C. Wendling, M.-C. Rio, and C. Tomasetto Functional Characterization of the MENTAL Domain J. Biol. Chem., May 6, 2005; 280(18): 17945 - 17952. [Abstract] [Full Text] [PDF]

				T. Kreiner and K. T. Buck Moving toward whole-genome analysis: A technology perspective Am. J. Health Syst. Pharm., February 1, 2005; 62(3): 296 - 305. [Abstract] [Full Text] [PDF]

				S. Uccini, O. Mannarino, H. P. McDowell, U. Pauser, R. Vitali, P. G. Natali, P. Altavista, T. Andreano, S. Coco, R. Boldrini, et al. Clinical and Molecular Evidence for c-kit Receptor as a Therapeutic Target in Neuroblastic Tumors Clin. Cancer Res., January 1, 2005; 11(1): 380 - 389. [Abstract] [Full Text] [PDF]

				O. Modlich, H.-B. Prisack, M. Munnes, W. Audretsch, and H. Bojar Immediate Gene Expression Changes After the First Course of Neoadjuvant Chemotherapy in Patients with Primary Breast Cancer Disease Clin. Cancer Res., October 1, 2004; 10(19): 6418 - 6431. [Abstract] [Full Text] [PDF]

				S. M. Baxter, J. S. Rosenblum, S. Knutson, M. R. Nelson, J. S. Montimurro, J. A. Di Gennaro, J. A. Speir, J. J. Burbaum, and J. S. Fetrow Synergistic Computational and Experimental Proteomics Approaches for More Accurate Detection of Active Serine Hydrolases in Yeast Mol. Cell. Proteomics, March 1, 2004; 3(3): 209 - 225. [Abstract] [Full Text] [PDF]